Today: 29 April 2026
KLA stock rebounds after ASE flags big advanced-packaging push — what KLAC traders watch next
5 February 2026
1 min read

KLA stock rebounds after ASE flags big advanced-packaging push — what KLAC traders watch next

New York, Feb 5, 2026, 15:27 EST — Regular session

  • KLA shares gained roughly 2.3% in afternoon trading, following a close at $1,307.22 the previous day
  • ASE projected its advanced-packaging segment to double by 2026 and revealed plans for increased machinery investment
  • An Argus note raised KLA’s target price to $1,750 but maintained its buy rating

KLA Corp shares climbed roughly 2.3% to $1,337.09 Thursday afternoon, recovering alongside other chip-tool stocks following a rough start to the week.

This move is crucial as investors look for clear evidence that chip-industry capital expenditures are holding steady, despite growing jitters about returns on AI-driven expansions. KLA provides inspection and metrology equipment that chipmakers rely on to detect defects and safeguard yields—a type of spending that often shifts when customers start cutting back.

ASE Technology in Taiwan projects its advanced packaging segment — where chips are linked or stacked for high-end processors — to hit $3.2 billion by 2026, doubling from current levels. CFO Joseph Tung emphasized the company’s continued push in capital expenditure, highlighting plans for an additional $1.5 billion in machinery investments this year.

Separately, Reuters revealed that an ASE unit bought machinery from KLA for T$1.14 billion.

KLA has been shedding ground recently. On Tuesday, the stock dropped 3.89%, ending the day at $1,355.54. That puts it nearly 20% below its 52-week peak of $1,693.35, which it reached on Jan. 29, according to a report.

The gains weren’t limited to one stock. Applied Materials climbed roughly 1.8%, Lam Research advanced close to 2.0%, and ASML ticked up about 0.8% during the session.

Big tech and the AI trade hit a rough patch. “The AI trade which was the accelerant last year is perhaps the extinguisher this year,” Melissa Brown, SimCorp’s managing director of investment decision research, told Reuters. Her comments came after Alphabet’s spending plans and Qualcomm’s forecast shook investors. MarketScreener UK

Argus raised its price target on KLA to $1,750 from $1,400, maintaining a buy rating, MT Newswires reported Wednesday.

That risk hasn’t disappeared. If customers hold off on ordering tools, or if the broader “risk-off” mood continues to drain cash from expensive tech stocks, KLA could lose its recent gains fast, even on days when semiconductor stocks try to hold steady.

Traders are gearing up for key macro data that could shift rate expectations. The U.S. Employment Situation report for January is set for Feb. 11, followed closely by January’s CPI on Feb. 13, per the Bureau of Labor Statistics schedule.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:55 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court
Previous Story

JNJ stock rises as Johnson & Johnson takes talc shareholder fight to U.S. Supreme Court

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote
Next Story

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Go toTop